Eyenuk Inc.’s AI-based diabetic retinopathy screening software EyeArt™ tested with portable smartphone-based imaging device in new study indicating potential for highly sensitive yet cost-effective mass retinal screening

Nature Eye Article

A new study published in the international ‘Eye’ journal (Springer Nature) demonstrated very high sensitivity for detecting any diabetic retinopathy (95.8%) and sight-threatening diabetic retinopathy (99.1%) using EyeArt™ automated screening software with Remidio Fundus on Phone system. LOS ANGELES, CA, March 12, 2018 — Eyenuk, Inc., a leading developer of advanced clinically supported artificial intelligence […]

Continue Reading »

Eyenuk, Inc. Receives Health Canada Approval for EyeArt™, an AI-enabled Cloud-based Automated Diabetic Retinopathy Screening Software

MDSAP_Certified_Health_Canada_Approved_EyeArt

Eyenuk’s quality management system has been registered under the Medical Device Single Audit Program (“MDSAP”) as conforming to the requirements of ISO 13485:2003, after successfully completing an audit for the relevant quality management system requirements of the U.S. Food and Drug Administration and Health Canada. LOS ANGELES, CA, March 8, 2018 — Eyenuk, Inc., a […]

Continue Reading »

Large UK National Health Services (NHS) Study Finds Eyeart Device To Be The Most Sensitive Automated Retinal Image Analysis Technology For Diabetic Retinopathy Screening

WOODLAND HILLS, Calif. – May 2, 2016 – Eyenuk, Inc., developer of advanced retinal image analysis solutions to identify eye disease, today announced results from the first large-scale, independent, comparative study of automated diabetic retinopathy (DR) screening technologies, showing that its EyeArt™ software device rated highest among those tested in sensitivity across all types of […]

Continue Reading »

Eyenuk, Inc. at ARVO 2016 (April 30-May 5)

ARVO_2016_Seattle_Logo

Eyenuk, Inc. will be attending the ARVO 2016 conference in Seattle, Washington from April 30th through May 5th. Eyenuk CEO, Kaushal Solanki, along with Sandeep Bhat, Chaithanya Ramachandra, and Malavika Bhaskaranand will present several posters on Eyenuk’s technology, including EyeArt™ Following is the list of presentations in chronological order Sat, Apr 30, 2016, 10:00-10:30am, Session […]

Continue Reading »

Eyenuk, Inc. at EASD Stockholm

easd logo

Eyenuk, Inc. will be attending the twenty-fifth EASDec 2015 conference in Stockholm Sweden from September 14th to Septeber 18th. Eyenuk CEO, Kaushal Solanki, will be presenting a poster on Eyenuk’s EyeArt™ technology. EASDec is a study group of the European Association for the Study of Diabetes (EASD) with special responsibility for the study of the […]

Continue Reading »

Eyenuk, Inc. presents EyeArt™ at EASDec 2015 in Turin

EASDec_2015

Eyenuk, Inc. will be attending the twenty-fifth EASDec 2015 conference in Turin Italy from June 26th to June 28th. Along with hosting a booth, Eyenuk CEO, Kaushal Solanki, will be presenting Eyenuk’s EyeArt™ technology during Session 4 of the conference: “Automated Grading: Real Life Experience” on Saturday June 27 at 15:15.. EASDec is a study […]

Continue Reading »

Eyenuk, Inc. granted CE marking for EyeArt

CE_logo_nemko_EyeArt_resized

Eyenuk, Inc. announced today that it received CE Marking for its pioneering EyeArt software, a suite of advanced image analysis tools for automated high-throughput screening of diabetic retinopathy. The company plans to launch its product in selected leading eye-care sites across Europe in the next few months. Diabetic Retinopathy (DR), a common microvascular complication of […]

Continue Reading »